Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. John J. Alam M.D. | Co-Founder, CEO, President & Director | 680.25k | -- | 1962 |
| Dr. Sylvie L. Gregoire Pharm.D. | Co-Founder & Director | 352.43k | -- | 1961 |
| Mr. William Robert Elder J.D. | CFO & General Counsel | 407.55k | -- | 1983 |
| Dr. Robert J. Cobuzzi Jr., Ph.D. | COO & Director | 386.6k | -- | 1965 |
| Ms. Kelly Blackburn M.H.A. | Senior Vice President of Clinical Development | 404.94k | -- | 1964 |
| Dr. Mark A. De Rosch Ph.D. | SVP of Regulatory & Government Affairs & Program Management | -- | -- | 1963 |
| Dr. Claudia Ordonez M.D. | Senior Vice President of Medical Science | -- | -- | 1966 |
CervoMed Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 8
Description
CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Corporate Governance
Upcoming Events
November 12, 2024 at 12:00 PM UTC
CervoMed Inc. Earnings Date
Recent Events
October 8, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission